Clinical Value of Capecitabine-Based Combination Adjuvant Chemotherapy in Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

Oncol Res · 2017 · PMC7841120 · PMID 28337954

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp = 0.06so close (0.05 < p ≤ 0.1)

The overall analysis of capecitabine-based versus capecitabine-free group yielded a borderline significant result in OS (HR = 0.91, 95% CI = 0.82–1.00, p = 0.06) ( Fig. 3 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.